• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » NIH to boost COVID-19 testing capabilities

NIH to boost COVID-19 testing capabilities

September 3, 2020 By Sean Whooley

coronavirus COVID-19 FDA HHS tests
[Photo by Fusion Medical Animation on Unsplash]
The National Institutes of Health announced a $129.3 million plan to support scaling and manufacturing for COVID-19 tests.

As part of its Rapid Acceleration of Diagnostics (RADx) initiative, NIH is awarding contracts to nine companies for their technologies that include portable point-of-care tests for immediate results and high-throughput laboratories that can produce results in 24 hours.

Yesterday’s announcement follows a July investment in seven companies from NIH worth $248.7 million in new technologies to address challenges with COVID-19 testing.

Some of the testing technologies are also being supported by the Biomedical Advanced Research and Development Authority (BARDA) as part of the U.S. Dept. of Health and Human Services, along with Defense Advanced Research Projects Agency (DARPA), in the U.S. Defense Dept.

Here are the nine companies receiving funding from the NIH to boost COVID-19 testing capabilities:

Point-of-care tests

  • MatMaCorp, Lincoln, Neb.
    • A portable mini-lab for rapidly performing multiple RT-PCR assays in a single platform.
  • Maxim Biomedical Inc, Rockville, Md.
    • A single-use, lateral-flow test strip immunoassay touted as capable of offering results in 15 minutes or less.
  • MicroGEM International, Charlottesville, Va.
    • A portable saliva test that provides results in 15 minutes and can potentially detect multiple pathogens simultaneously (such as influenza).

Lab-based tests

  • Aegis Sciences, Nashville, Tenn.
    • A nucleic acid detection kit using nasal and oral swab samples, offering capacity of 15,000 samples per day with eyes on reaching 60,000 per day. Results return in 24 hours or less.
  • Broad Institute, Cambridge, Mass.
    • Uses nasal swabs and already performs tests for more than 530 regional hospitals, nursing homes and other facilities in vulnerable communities. The award will help to increase capacity from 25,000 to 100,000 tests per day.
  • Ceres Nanoscience Inc, Manassas, Va.
    • Uses nanotrap particles to extract and concentrate viral material to reduce processing time and improve sensitivity.
  • Illumina, San Diego, Calif.
    • Automated sample processing that has a capacity which can be expanded to 48,000 tests per day and can process the tests within 24 hours.
  • PathGroup, Nashville, Tenn.
    • Uses Roche 6800 and Hologic Panther instruments to process about 10,000 COVID-19 RNA tests per day and aims to increase the capacity to 80,000 per day by December.
  • Sonic Healthcare USA, Austin, Texas
    • Using specimens from mostly nasal swabs, the capacity can reach up to 166,000 samples tested per day.

 

“Diagnostic testing is a critical component of the nation’s strategy to meet the challenge of the COVID-19 pandemic,” NIH director Dr. Francis Collins said in a news release. “Just started at the end of April, the RADx initiative has moved swiftly to speed innovation and later-stage development in the biomedical technology sector. The results thus far have been outstanding.”

Filed Under: Business/Financial News, Diagnostics, Featured, Funding Roundup, Genomics/Molecular Diagnostics Tagged With: Aegis Sciences, Broad Institute, Ceres Nanoscience, coronavirus, COVID-19, Illumina Inc., MatMaCorp, Maxim Biomedical, MicroGEM International, National Institutes of Health (NIH), NIH, PathGroup, Sonic Healthcare USA

More recent news

  • Data backs DermaSensor skin cancer detection device
  • GE HealthCare expands digital imaging portfolio with enhanced MIM Encore software
  • Accelus wins FDA clearance for MRI compatibility of FlareHawk spinal implants
  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy